Receptor for granulocyte colony-stimulating factor (CSF3), essential for granulocytic maturation.
Drugs that act on it: 10
Approved: 6
In phases 1 to 3: 4
Sponsors: 6
Who is on it, and how far along
Every drug ChEMBL records acting on CSF3R, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Antibody 1
Protein or peptide 9
Approved6
FilgrastimFilgrastimSponsorMerck & Co. (MSD)ModalityProtein or peptideActionAgonistOpen trials228
LenograstimLenograstimSponsorMerck & Co. (MSD)ModalityProtein or peptideActionAgonistOpen trials227
LipegfilgrastimLipegfilgrastimSponsorMerck & Co. (MSD)ModalityProtein or peptideActionAgonistOpen trials64
PegfilgrastimPegfilgrastimSponsorMerck & Co. (MSD)ModalityProtein or peptideActionAgonistOpen trials64
Efbemalenograstim alfaEfbemalenograstim alfaSponsorEvive BiotechnologyModalityProtein or peptideActionAgonistOpen trials3
EflapegrastimEflapegrastimSponsorSpectrum PharmaceuticalsModalityProtein or peptideActionAgonistOpen trials1
Phase 31
RegramostimRegramostimSponsorSavara Inc.ModalityProtein or peptideActionAgonistOpen trials4
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 9 of 10 act as: Granulocyte colony stimulating factor receptor agonist; the rest name their own mechanism.
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1996, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt Q99062, CC BY 4.0) and disease associations are from Open Targets (CC0).ChEMBL and Open Targets
Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.